High Expression of TIMELESS Predicts Poor Prognosis: A Potential Therapeutic Target for Skin Cutaneous Melanoma

被引:5
|
作者
Zhao, Shixin [1 ]
Wen, Shifeng [2 ]
Liu, Hengdeng [1 ]
Zhou, Ziheng [1 ]
Liu, Yiling [1 ]
Zhong, Jinbao [3 ]
Xie, Julin [1 ]
机构
[1] Sen Univ, Affiliated Hosp Sun Yat 1, Dept Burn Surg, Guangzhou, Peoples R China
[2] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Dept Orthoped, Guangzhou, Peoples R China
[3] Guangzhou Inst Dermatol, Dept Dermatol, Guangzhou, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
skin cutaneous melanoma; prognostic signature; overall survival; timeless; immune infiltration; bioinformatics; CIRCADIAN CLOCK; GENE-EXPRESSION; IMMUNE CELLS; T-CELLS; CANCER; METASTASIS; PROGRESSION; MIGRATION; PROMOTES; ADHESION;
D O I
10.3389/fsurg.2022.917776
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Skin cutaneous melanoma (SKCM) is the most lethal skin cancer with an increasing incidence worldwide. The poor prognosis of SKCM urgently requires us to discover prognostic biomarkers for accurate therapy. As a regulator of DNA replication, TIMELESS (TIM) has been found to be highly expressed in various malignancies but rarely reported in SKCM. The objective of this study was to evaluate the relationship between TIM and SKCM tumorigenesis and prognosis. Methods We obtained RNA sequencing data from TCGA and GTEx to analyze TIM expression and differentially expressed genes (DEGs). Subsequently, GO/KEGG, GSEA, immune cell infiltration analysis, and protein-protein interaction (PPI) network were used to perform the functional enrichment analysis of TIM-related DEGs. Moreover, the receiver operating characteristic (ROC) curves, Cox regression analysis, Kaplan-Meier (K-M) analysis, and nomograms were applied to figure out the clinical significance of TIM in SKCM. In addition, we investigated the relationship between TIM promoter methylation and SKCM prognosis through the UALCAN database. Finally, the immunohistochemical (IHC) results of normal skin and SKCM were analyzed to determine expression differences. ResultsTIM was significantly elevated in various m alignancies, including SKCM, and high expression of TIM was associated with poor prognosis. Moreover, a total of 402 DEGs were identified between the two distinct TIM expression groups, and functional annotation showed enrichment with positive regulation of cell cycle and classic oncogenic pathways in the high TIM expression phenotype, while keratinization pathways were negatively regulated and enriched. Further analysis showed that TIM was correlated with infiltration of multiple immune cells. Finally, IHC validated the differential expression of TIM in SKCM. Conclusion TIM might play a pivotal role in tumorigenesis of SKCM and is closely related to its prognosis.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Increased Expression of TICRR Predicts Poor Clinical Outcomes: A Potential Therapeutic Target for Papillary Renal Cell Carcinoma
    Xia, Shuang
    Lin, Yan
    Lin, Jiaqiong
    Li, Xiaoyong
    Tan, Xuexian
    Huang, Zena
    FRONTIERS IN GENETICS, 2021, 11
  • [42] Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
    Xu, Ziqian
    Xie, Yihui
    Mao, Yaqi
    Huang, Juntao
    Mei, Xingyu
    Song, Jun
    Sun, Yue
    Yao, Zhixian
    Shi, Weimin
    FRONTIERS IN GENETICS, 2021, 12
  • [43] Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM)
    Zhang, Shuguang
    Chen, Kun
    Zhao, Zhenguo
    Zhang, Xinxin
    Xu, Libin
    Liu, Ting
    Yu, Shengji
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (06) : 274 - 283
  • [44] Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma
    Poukka, Mari
    Bykachev, Andrey
    Siiskonen, Hanna
    Tyynela-Korhonen, Kristiina
    Auvinen, Paivi
    Pasonen-Seppanen, Sanna
    Sironen, Reijo
    BMC CANCER, 2016, 16
  • [45] Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma
    Mari Poukka
    Andrey Bykachev
    Hanna Siiskonen
    Kristiina Tyynelä-Korhonen
    Päivi Auvinen
    Sanna Pasonen-Seppänen
    Reijo Sironen
    BMC Cancer, 16
  • [46] Identification of significant genes with a poor prognosis in skin cutaneous malignant melanoma based on a bioinformatics analysis
    Wang, Jin
    Yang, Jilong
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (08)
  • [47] Smoking is an Independent Marker of Poor Prognosis in Cutaneous Melanoma
    Mattila, Kalle
    Vihinen, Helmi
    Karlsson, Antti
    Minn, Heikki
    Vihinen, Pia
    Heervae, Eetu
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [48] BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma
    Sabnis, Durgagauri H.
    Liu, Jo-Fen
    Simmonds, Lucy
    Blackburn, Sophie
    Grundy, Richard G.
    Kerr, Ian D.
    Coyle, Beth
    CANCERS, 2021, 13 (09)
  • [49] High expression of ezrin predicts poor prognosis in uterine cervical cancer
    Kong, Jienan
    Li, Yan
    Liu, Shuangping
    Jin, Haidan
    Shang, Yongjun
    Quan, Chengshi
    Li, Yulin
    Lin, Zhenhua
    BMC CANCER, 2013, 13
  • [50] High expression of GMNN predicts malignant progression and poor prognosis in ACC
    Zhao, Xinzhao
    Zhang, Xuezhou
    Shao, Shixiu
    Yang, Qingbo
    Shen, Chengquan
    Yang, Xuecheng
    Jiao, Wei
    Liu, Jing
    Wang, Yonghua
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)